MyFinsight
Home
Blog
About
Contact
Cash and cash
equivalents
$4,219,099
Accounts receivable, net
$201,481
Prepaid expenses and
other current assets
$175,174
Inventory
$104,523
Total property and
equipment
$540,452
Total current assets
$4,700,277
Right-of-use assets, net
$562,507
License agreement, net
$265,518
Intangible asset, net
$206,801
Property and equipment,
net
$45,187
Other assets
$23,057
Less accumulated
depreciation
$495,265
Total assets
$5,803,347
Total liabilities,
contingently redeemable...
$5,803,347
Total liabilities
$3,046,222
Total stockholders
(deficit) equity
$2,552,886
Series e convertible
preferred stock, 0.01 par...
$204,239
Accumulated deficit
-$35,422,055
Total current
liabilities
$2,580,045
Total long-term
liabilities
$466,177
Additional paid-in capital
$37,870,511
Common stock, 0.01 par
value 50,000,000...
$104,430
Accounts payable
$980,486
Accrued liabilities
$598,335
Deferred revenue
$450,667
Convertible note
$306,716
Operating lease liability
current
$189,649
Accrued dividends
series e convertible...
$54,192
Operating lease liability
long term
$429,122
Deferred revenue
long-term
$37,055
Back
Back
Balance Sheet
20 20 Biolabs, Inc. (AIDX)
20 20 Biolabs, Inc. (AIDX)
source: myfinsight.com